The database retrieval returned no text results, so I will construct a comprehensive answer from my expert medical knowledge, supplemented by the histopathology image retrieved.
Nevus Cutaneous Lipomatosus Superficialis (NCLS)
Detailed Clinical Note for MS General Surgery Poster Presentation
1. DEFINITION & NOMENCLATURE
Nevus Cutaneous Lipomatosus Superficialis (NCLS), also called Nevus Lipomatosus Superficialis (NLS) or Hoffmann-Zurhelle nevus, is a rare, benign hamartomatous lesion of the skin characterized by the ectopic deposition of mature adipose tissue within the dermis, specifically in the upper and middle reticular dermis — a location where fat is not normally found.
- First described by Hoffmann and Zurhelle in 1921
- Classified under connective tissue hamartomas / benign mesenchymal neoplasms
- ICD-10: D22.9 / Q82.8 (benign melanocytic nevus / other specified congenital malformations of skin)
2. EPIDEMIOLOGY
| Parameter | Details |
|---|
| Prevalence | Rare; exact incidence unknown |
| Age of onset | Congenital or appears in 1st–2nd decade (classic form); any age (solitary form) |
| Sex predilection | Slight female predominance in some series |
| Race | No racial predilection |
| Hereditary pattern | Sporadic; rarely familial |
3. PATHOGENESIS & ETIOLOGY
The exact etiology remains unclear. Proposed mechanisms include:
- Hamartomatous differentiation — aberrant differentiation of pluripotent mesenchymal cells in the dermis into mature adipocytes
- Ectopic lipogenesis — perivascular connective tissue or fibroblast precursors undergo lipogenesis under unknown stimuli
- Nevoid malformation — considered a localized developmental error (nevoid origin) rather than a true neoplasm
- Embryological arrest theory — arrest of maturation of dermal mesenchymal cells during fetal development, retaining adipogenic potential
- Some authors postulate a somatic mutation in PTEN or PIK3CA pathway (analogous to other hamartomas), though not definitively proven
No proven association with systemic lipomatosis, chromosomal abnormalities, or malignant transformation.
4. CLASSIFICATION
Type I — Classic / Hoffmann-Zurhelle Type (Zosteriform / Multiple)
- Multiple soft, yellowish, skin-colored papules and nodules grouped in a cerebriform, zosteriform, or clustered configuration
- Present at birth or appears in childhood/early adulthood (before age 30)
- Typically located on the lower trunk (lumbo-gluteal region, buttocks, flanks, thighs)
- Lesions may coalesce forming plaques with a cobblestone or cerebriform surface
- Does not cross the midline (follows Blaschko's lines in some cases)
Type II — Solitary / Acquired Type
- Single, dome-shaped soft pedunculated nodule or papule
- Appears in adults (3rd–5th decade)
- Can occur anywhere — scalp, face, ear (tragus), trunk, extremities
- Smaller, more discrete than Type I
- The histopathology image above shows this type — a pedunculated nodule on the tragus
A third rare variant — associated with folliculosebaceous cystic hamartoma and comedone-like lesions has been described.
5. CLINICAL FEATURES
Symptoms
- Usually asymptomatic
- Occasionally: mild pruritus, tenderness on pressure, cosmetic concern
- No constitutional symptoms
Signs
| Feature | Classic Type I | Solitary Type II |
|---|
| Number | Multiple (5–100+) | Single |
| Size | 0.5–3 cm (individual) | 0.5–5 cm |
| Shape | Papules/nodules → plaques | Dome-shaped, pedunculated nodule |
| Color | Skin-colored to pale yellow | Skin-colored to yellowish |
| Surface | Smooth, cerebriform, or verrucous | Smooth |
| Consistency | Soft, doughy, non-tender | Soft, compressible |
| Location | Buttocks, flanks, lower trunk | Scalp, face, ear, any site |
| Onset | Congenital/childhood | Adult |
| Growth | Slow, stable after puberty | Slow progressive |
| Comedones | May be present (hair follicle obliteration) | Absent |
Associated Features (Type I)
- Telangiectasia within plaques
- Hyperpigmentation or hypopigmentation
- Comedone-like plugs at follicular ostia
- Focal alopecia over lesional skin
6. HISTOPATHOLOGY
This is the gold standard for diagnosis.
Histopathology: Surgical excision specimen showing mature adipocytes in lobules within the reticular dermis, no atypia — diagnostic of NLS (WebPathology)
Microscopic Features:
| Layer | Finding |
|---|
| Epidermis | Normal or mildly acanthotic; sometimes papillomatous |
| Papillary dermis | Usually normal |
| Reticular dermis (upper & mid) | Mature adipocytes in lobules — pathognomonic finding |
| Adipocytes | Uniform, clear cytoplasm, small compressed nuclei — NO atypia, NO mitoses |
| Stroma | Fibrous bands separating lobules |
| Vasculature | Dilated capillaries (sometimes); no angiomatosis |
| Adnexae | May be displaced or diminished |
| Deep dermis/subcutis | No infiltration (distinguishes from lipoma) |
| Inflammatory infiltrate | Absent or sparse |
Key Histological Diagnostic Criterion:
Mature adipocytes occupying >10% of the dermis, present in the upper/mid reticular dermis without connection to subcutaneous fat — Diagnostic hallmark
7. DERMOSCOPY
- Yellowish-white structureless areas corresponding to dermal fat deposits
- Dilated follicular ostia
- Fine vessels in a reticular pattern
- No pigment network (differentiates from melanocytic lesions)
- Helpful non-invasive pre-operative tool
8. IMAGING
| Modality | Findings |
|---|
| Ultrasound | Hyperechoic dermal mass; sharply circumscribed; no subcutaneous extension |
| MRI | T1 hyperintense (fat signal); T2 hyperintense; no enhancement; restricted to dermis |
| CT | Hypodense lesion within dermis |
Imaging is rarely needed but useful for large lesions or when liposarcoma is a concern.
9. DIAGNOSIS
Clinical Diagnosis:
- Based on characteristic morphology and location
- Type I (zosteriform multiple lesions over buttocks in a young patient) is often clinically diagnosed
Definitive Diagnosis:
- Excisional biopsy + Histopathology — required for confirmation, especially solitary lesions
Diagnostic Criteria (Proposed):
- Soft, skin-colored/yellowish papules/nodules in dermis
- No connection to subcutaneous fat clinically or histologically
- Mature adipocytes in the dermis on histology
- No atypia or malignant features
10. DIFFERENTIAL DIAGNOSIS
| Condition | Differentiating Features |
|---|
| Intradermal lipoma | Deeper, not in dermis proper; larger; subcutaneous |
| Angiofibromas (tuberous sclerosis) | Facial, associated with TSC features, different histology |
| Connective tissue nevus | No adipocytes; collagen/elastic tissue proliferation |
| Folliculo-sebaceous cystic hamartoma | Overlapping; differentiated by follicular cysts on histology |
| Epidermal nevus | Epidermal proliferation predominates |
| Pedunculated lipofibroma | Fibrous component > adipose; firm |
| Fibrolipoma | More fibrous stroma; subcutaneous origin |
| Well-differentiated liposarcoma | Nuclear atypia, lipoblasts, MDM2/CDK4 amplification |
| Neurofibroma | S100+, neural origin; no mature adipocytes |
| Focal dermal hypoplasia (Goltz syndrome) | X-linked, skin atrophy with herniation of fat, skeletal anomalies |
| Michelin tire baby syndrome | Diffuse skin folds, generalized smooth muscle hamartoma |
11. MANAGEMENT
Indications for Surgery:
- Cosmetic disfigurement / patient request
- Mechanical symptoms (friction, difficulty wearing clothing)
- Diagnostic uncertainty (to rule out malignancy)
- Pedunculated lesion prone to trauma/torsion
- Rapid increase in size (though rare)
Surgical Treatment:
Wide Local Excision (Treatment of Choice)
- Excision with adequate margins down to and including upper subcutaneous fat
- Full-thickness skin excision ensures complete removal of all ectopic fat lobules
- Orientation of incision along Langer's lines for optimal cosmesis
- Closure: primary closure for small lesions; flap or skin graft for large plaques
Liposuction (Adjunctive)
- Used for large, extensive Type I lesions (zosteriform plaques)
- Reduces bulk and improves contour
- Risk of recurrence higher than excision alone
- May be combined with excision
CO₂ Laser Ablation
- Reported for small, superficial lesions
- Less scarring but incomplete depth of treatment → higher recurrence
- Not standard of care for MS General Surgery
Nd:YAG Laser
- Limited evidence; experimental
Recurrence:
- Low recurrence rate with complete excision
- Incomplete excision → local recurrence
- No malignant transformation reported
Prognosis:
- Excellent — purely benign lesion
- No systemic involvement
- No malignant potential
- Psychosocial impact addressed by surgical correction
12. COMPLICATIONS
| Complication | Details |
|---|
| Surgical wound infection | Standard post-op risk |
| Seroma/hematoma | Especially for large excisions |
| Scar hypertrophy/keloid | Depending on patient tendency |
| Recurrence | With incomplete excision |
| Cosmetic dissatisfaction | For large lesions requiring grafts |
13. SPECIAL CONSIDERATIONS FOR SURGEONS
- Always send specimen for HPE — mandatory to confirm benignity
- For gluteal/lower trunk lesions: position patient prone, use tourniquet if needed for hemostasis, plan incision for ease of closure
- For solitary lesions on face/ear: consider cosmetic implications, use loupe magnification, ensure clean margins
- Rule out liposarcoma in any atypical or rapidly growing lesion — send for MDM2/CDK4 FISH if histologically borderline
- No role for chemotherapy, radiotherapy, or immunotherapy — purely surgical condition
14. SUMMARY TABLE
| Feature | Details |
|---|
| Type | Benign hamartoma |
| Tissue | Ectopic mature dermis adipocytes |
| Classic site | Buttocks, lower trunk (Type I); anywhere (Type II) |
| Age | Childhood (Type I); adults (Type II) |
| Diagnosis | Histopathology |
| Treatment | Wide local excision |
| Recurrence | Low (with complete excision) |
| Malignant potential | None |
CROSS QUESTIONS & ANSWERS FOR POSTER PRESENTATION
(Expected from MS General Surgery Professor)
Q1. What is the pathognomonic histological finding in NCLS?
A: The pathognomonic finding is the presence of mature adipocytes occupying the upper and middle reticular dermis, arranged in lobules, without cytological atypia, mitoses, or lipoblasts, and without connection to the subcutaneous fat. This ectopic dermal location of mature fat is what defines the condition.
Q2. How do you differentiate NCLS from a simple intradermal lipoma clinically and histologically?
A: Clinically, a lipoma is a subcutaneous lesion — you can feel the skin move freely over it, it is deeper, and usually larger. NCLS, in contrast, is within the dermis itself — the lesion is part of the skin. Histologically, in NCLS, the adipocytes are confined to the dermis, particularly the reticular dermis, and there is no connection to subcutaneous fat. In a lipoma, the fat is in the subcutaneous plane, may be encapsulated, and is separated from the dermis.
Q3. Can NCLS undergo malignant transformation?
A: No. NCLS is a benign hamartomatous lesion with no documented cases of malignant transformation. However, if any lesion shows rapid growth, induration, or atypical features, a biopsy is mandatory to exclude a primary liposarcoma, which can rarely mimic NCLS clinically, especially the well-differentiated subtype.
Q4. What are the key differences between Type I and Type II NCLS?
A:
| Parameter | Type I (Classic) | Type II (Solitary) |
|---|
| Number | Multiple | Single |
| Age | Birth/childhood | Adults (3rd–5th decade) |
| Location | Buttocks, lower trunk | Any site (scalp, ear, face) |
| Configuration | Zosteriform/grouped | Isolated nodule |
| Prognosis | Same — benign | Same — benign |
Q5. What is your surgical plan for a large zosteriform NCLS over the gluteal region?
A: For a large gluteal NCLS, I would:
- Perform a preoperative MRI to delineate extent and rule out deep infiltration
- Plan wide local excision with margins under GA, patient in prone position
- Ensure full-thickness skin excision to the upper subcutaneous fat
- For very large lesions, consider staged excision or liposuction for debulking followed by excision of residual skin
- Closure with rotation flap or split-thickness skin graft if primary closure is not possible
- Send entire specimen for histopathological examination
Q6. Why do ectopic adipocytes appear in the dermis in NCLS?
A: The exact mechanism is not fully elucidated. The leading hypothesis is a hamartomatous developmental defect where pluripotent mesenchymal cells in the dermis aberrantly differentiate into mature adipocytes instead of normal dermal fibroblasts. Some theories suggest somatic mutations in lipogenic signaling pathways (e.g., PI3K/AKT/mTOR), similar to other hamartomatous syndromes. It is not a metaplastic change and not due to trauma or herniation of subcutaneous fat.
Q7. How does NCLS differ from Focal Dermal Hypoplasia (Goltz syndrome)?
A: Both can show fat within the dermis, but they are distinct:
- Goltz syndrome is an X-linked condition with widespread skin atrophy, telangiectasias, skeletal abnormalities (syndactyly, osteopathia striata), ocular anomalies, and dental defects. The fat appears through atrophic skin as a herniation.
- NCLS is localized, sporadic, has no systemic associations, no skin atrophy, and the fat is truly within the dermis as a hamartoma, not herniating from subcutaneous tissue.
Q8. What stains confirm the adipocytic nature of NCLS on histology?
A:
- H&E: Shows mature adipocytes — large cells with clear vacuolated cytoplasm and peripherally compressed nuclei
- Oil Red O / Sudan IV: Positive staining for lipid in fresh/frozen sections
- S100: Negative — differentiates from neural tumors
- MDM2/CDK4 immunohistochemistry or FISH: Negative — rules out well-differentiated liposarcoma
- CD34: May show stromal positivity (non-specific)
Q9. What is the recurrence rate after surgical excision, and how do you prevent it?
A: Recurrence with complete excision is rare (<5%). To prevent recurrence:
- Ensure full-thickness excision down to and including the superficial subcutaneous fat
- Confirm clear margins on frozen section if clinically uncertain
- Avoid superficial shave excision or incomplete removal
- For liposuction-based treatment of large lesions, counsel patient about higher recurrence rates (~20–30%) compared to excision
Q10. A 25-year-old woman presents with multiple soft yellowish nodules over the right buttock since childhood. No family history. What is your approach?
A:
- Clinical diagnosis — History (since childhood, buttock, multiple, soft, yellow) is strongly suggestive of Type I NCLS
- Dermoscopy — Yellow-white structureless areas, no pigment network
- Excisional biopsy of representative lesion — Confirm with HPE
- Once confirmed benign: counseling — inform patient of benign nature, no malignant potential
- Surgical excision if cosmetically distressing or symptomatic
- No systemic workup needed — NCLS has no systemic associations
Q11. How is NCLS related to Michelin tire baby syndrome?
A: Michelin tire baby syndrome (generalized smooth muscle hamartoma) is a distinct entity where the entire body shows redundant skin folds. Some cases have shown overlap with NCLS features histologically — mature dermal adipocytes. However, NCLS is localized, whereas Michelin tire syndrome is generalized with a different hamartomatous component (smooth muscle). They represent different points on the spectrum of mesenchymal hamartomas of the skin.
Q12. What is the embryological basis of the typical location of Type I NCLS (buttocks/lower trunk)?
A: The predilection for the lumbo-gluteal region is thought to reflect areas where during embryogenesis, the dermomyotome contributes dermal precursor cells with higher adipogenic potential. The zosteriform pattern along Blaschko's lines suggests a somatic mosaicism — a post-zygotic mutation affecting a clone of cells following developmental migration lines. The buttocks represent a high-fat region developmentally, making ectopic adipogenesis more likely in this zone.
Q13. If the HPE report reads "adipocytes in the dermis with mild nuclear pleomorphism" — how will you proceed?
A: Mild pleomorphism raises concern for atypical lipomatous tumor / well-differentiated liposarcoma (ALT/WDLPS). I would:
- Review slides with a dedicated dermatopathologist/surgical pathologist
- Order MDM2 and CDK4 immunohistochemistry — positive in ALT/WDLPS
- Send for MDM2 FISH — amplification of chromosome 12q13-15 confirms WDLPS
- If confirmed malignant: re-excision with wide clear margins, oncology referral
- If negative for MDM2/CDK4: likely benign atypical NCLS — close follow-up with re-excision if incomplete margins
Q14. What is the role of dermoscopy in NCLS?
A: Dermoscopy serves as a non-invasive diagnostic tool to:
- Identify the yellowish structureless areas representing dermal fat
- Rule out melanocytic pathology (absence of pigment network)
- Identify dilated follicular openings and reticular vessels
- Guide decision for biopsy (helps clinician avoid unnecessary biopsy of classic cases)
- Not a substitute for histopathology in solitary or atypical lesions
Q15. What are the key points you would emphasize on a surgical poster for NCLS?
A: Key take-home messages for a surgical poster:
- NCLS = benign hamartoma — ectopic mature adipocytes in dermis
- Two types: Type I (multiple, congenital, buttocks) and Type II (solitary, adult, any site)
- Diagnosis confirmed by histopathology — mature adipocytes in dermis, no atypia
- Wide local excision is treatment of choice — curative, low recurrence
- No malignant potential — reassure patient
- Exclude well-differentiated liposarcoma in atypical cases via MDM2/CDK4
- Rare condition — thorough clinico-pathological correlation essential
QUICK REVISION MNEMONICS
"DERMIS FAT" for NCLS features:
-
Dermis — location of ectopic fat
-
Ectopic mature adipocytes
-
Rare hamartoma (Hoffmann-Zurhelle)
-
Multiple (Type I) or Mono/solitary (Type II)
-
Innocuous — no malignant potential
-
Surgery (wide excision) = cure
-
Fat in dermis = pathognomonic
-
Adult onset for Type II
-
Type I = congenital, zosteriform, buttocks
Note for Poster: The lesion is purely benign and surgical excision is curative. Always send HPE. The key message for a General Surgery audience is the distinction from liposarcoma and the confirmatory role of histopathology + MDM2/CDK4 testing when in doubt.